Shanghai Obio Technology (Group) Corp., Ltd.

¥6.49As of Sun 8 Nov 2026, 12:00 UTC
SSE:688238Healthcare
Country China
PE (Fwd) •••
TSR 5Y CAGR (17.35%)
Div yield —
ROE (15.96%)
Biotechnology
Beta (5Y) 0.57
PE TTM —
TSR TTM (13.35%)
Mkt cap ¥4.091B
ROIC (12.95%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥7.50
15.63%
32.75%
Hold 12|5|9|11|8
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.08
0.08
0.08
0.08
19.03%
17.63%
24.01%
16.46%
Revenue¥M
531.6
561.5
569.9
562.3
10.19%
13.09%
9.73%
4.51%
Peers (US$613.2M)
Cap (US$)
PE
603.7M
29.76x
Capital
TTM
5Y
10Y
Leveragex
2.295
0.014
0.014
EBIT/Intx
0.202
0.046
0.054
Own earn%
(184.51)
186.82
165.22
Sh yield%
40.19
38.02
43.59
Owners
Insiders/Inst%
14.15
29.40
Short interest%
3.42
SBC / revenue%
3.02
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
2
Op margin range%
28–34
$1 testx
—
Incr. ROIC%
5